JVI:HCMV感染NPCs初步研究获进展

2013-11-26 亦云 武汉病毒研究所

近期,中科院武汉病毒研究所罗敏华课题组在人神经干细胞体系的建立与人巨细胞病毒(HCMV)感染人神经干细胞初步研究中取得重要进展。相关结果发表于国际病毒学杂志Journal of Virology上。 先天性HCMV感染是导致出生缺陷的最常见病因,主要引起中枢神经系统(CNS)发育紊乱。先天性HCMV发生在早孕期,其后果常常比感染发生于孕晚期更严重,表现为严重脑损伤,包

近期,中科院武汉病毒研究所罗敏华课题组在人神经干细胞体系的建立与人巨细胞病毒(HCMV)感染人神经干细胞初步研究中取得重要进展。相关结果发表于国际病毒学杂志Journal of Virology上。

先天性HCMV感染是导致出生缺陷的最常见病因,主要引起中枢神经系统(CNS)发育紊乱。先天性HCMV发生在早孕期,其后果常常比感染发生于孕晚期更严重,表现为严重脑损伤,包括小脑畸形等。胎脑中HCMV感染最常见区域为室管膜下区(SVZ),其中细胞的主要类型是神经干/前体细胞(NPCs)。

因此,该课题组在体外重建HCMV感染的人神经干细胞(NPCs)模型,进一步研究和比较不同胚龄个体来源的NPCs HCMV感染,研究和比较体外长期培养对HCMV感染的影响发现,新分离的NPCs对HCMV感染是完全允许性;HCMV感染指标无明显差异,证明感染无个体差异。进一步研究和比较早期代数NPCs(9代内)和长时间培养后的晚期代数NPCs(11代以上)中HCMV感染特性,发现随着培养时间的推移,在晚期代数NPCs中CPE进展速度更快、释放更高水平病毒颗粒,伴有病毒基因表达水平改变;病毒侵入的效率更高。表明晚期代数的NPCs对HCMV的易感性更强。

在以往的研究中,研究者都是使用9代以内的NPCs进行研究HCMV的感染,并没有人具体研究过9代以后的NPCs对HCMV感染有何影响。本实验系统地研究了晚期代数和早期代数的NPCs对HCMV感染的差异,阐明了细胞形态、病毒基因表达、病毒颗粒释放的差异,并且基于这种差异进行了机理性研究,发现其可能与二者之间的NPCs分化状态和病毒受体的表达差异有关。

本研究能够给临床研究提供理论基础,揭示在病毒感染后期,HCMV对胎脑的神经损伤更严重,因此对于感染HCMV的孕妇,要及时治疗。人神经干细胞的体外培养及其对HCMV的易感性研究无论对神经生物学、干细胞、HCMV的感染机制都具有重要价值,该研究得到了国家自然科学基金的支持。


版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1801203, encodeId=b6d118012035c, content=<a href='/topic/show?id=d4bce344265' target=_blank style='color:#2F92EE;'>#研究获进展#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73442, encryptionId=d4bce344265, topicName=研究获进展)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0ad8182, createdName=axin009, createdTime=Sun Mar 30 04:38:00 CST 2014, time=2014-03-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1652656, encodeId=29e41652656db, content=<a href='/topic/show?id=0bb7491186' target=_blank style='color:#2F92EE;'>#CMV#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4911, encryptionId=0bb7491186, topicName=CMV)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3f5424318202, createdName=wolongzxh, createdTime=Sat Dec 07 00:38:00 CST 2013, time=2013-12-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1966881, encodeId=239e19668816c, content=<a href='/topic/show?id=91298559a0' target=_blank style='color:#2F92EE;'>#HCMV#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=8559, encryptionId=91298559a0, topicName=HCMV)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bf3d82, createdName=zhaohui6731, createdTime=Tue Feb 25 04:38:00 CST 2014, time=2014-02-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1685557, encodeId=98de168555e49, content=<a href='/topic/show?id=a340138e48a' target=_blank style='color:#2F92EE;'>#PCS#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13874, encryptionId=a340138e48a, topicName=PCS)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=173d28230918, createdName=Tamikia, createdTime=Tue Feb 04 13:38:00 CST 2014, time=2014-02-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1478109, encodeId=dfa114e810975, content=<a href='/topic/show?id=f51a8556cc' target=_blank style='color:#2F92EE;'>#HCM#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=8556, encryptionId=f51a8556cc, topicName=HCM)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8e886, createdName=仁者大医, createdTime=Thu Nov 28 02:38:00 CST 2013, time=2013-11-28, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1801203, encodeId=b6d118012035c, content=<a href='/topic/show?id=d4bce344265' target=_blank style='color:#2F92EE;'>#研究获进展#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73442, encryptionId=d4bce344265, topicName=研究获进展)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0ad8182, createdName=axin009, createdTime=Sun Mar 30 04:38:00 CST 2014, time=2014-03-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1652656, encodeId=29e41652656db, content=<a href='/topic/show?id=0bb7491186' target=_blank style='color:#2F92EE;'>#CMV#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4911, encryptionId=0bb7491186, topicName=CMV)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3f5424318202, createdName=wolongzxh, createdTime=Sat Dec 07 00:38:00 CST 2013, time=2013-12-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1966881, encodeId=239e19668816c, content=<a href='/topic/show?id=91298559a0' target=_blank style='color:#2F92EE;'>#HCMV#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=8559, encryptionId=91298559a0, topicName=HCMV)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bf3d82, createdName=zhaohui6731, createdTime=Tue Feb 25 04:38:00 CST 2014, time=2014-02-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1685557, encodeId=98de168555e49, content=<a href='/topic/show?id=a340138e48a' target=_blank style='color:#2F92EE;'>#PCS#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13874, encryptionId=a340138e48a, topicName=PCS)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=173d28230918, createdName=Tamikia, createdTime=Tue Feb 04 13:38:00 CST 2014, time=2014-02-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1478109, encodeId=dfa114e810975, content=<a href='/topic/show?id=f51a8556cc' target=_blank style='color:#2F92EE;'>#HCM#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=8556, encryptionId=f51a8556cc, topicName=HCM)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8e886, createdName=仁者大医, createdTime=Thu Nov 28 02:38:00 CST 2013, time=2013-11-28, status=1, ipAttribution=)]
    2013-12-07 wolongzxh
  3. [GetPortalCommentsPageByObjectIdResponse(id=1801203, encodeId=b6d118012035c, content=<a href='/topic/show?id=d4bce344265' target=_blank style='color:#2F92EE;'>#研究获进展#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73442, encryptionId=d4bce344265, topicName=研究获进展)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0ad8182, createdName=axin009, createdTime=Sun Mar 30 04:38:00 CST 2014, time=2014-03-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1652656, encodeId=29e41652656db, content=<a href='/topic/show?id=0bb7491186' target=_blank style='color:#2F92EE;'>#CMV#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4911, encryptionId=0bb7491186, topicName=CMV)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3f5424318202, createdName=wolongzxh, createdTime=Sat Dec 07 00:38:00 CST 2013, time=2013-12-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1966881, encodeId=239e19668816c, content=<a href='/topic/show?id=91298559a0' target=_blank style='color:#2F92EE;'>#HCMV#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=8559, encryptionId=91298559a0, topicName=HCMV)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bf3d82, createdName=zhaohui6731, createdTime=Tue Feb 25 04:38:00 CST 2014, time=2014-02-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1685557, encodeId=98de168555e49, content=<a href='/topic/show?id=a340138e48a' target=_blank style='color:#2F92EE;'>#PCS#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13874, encryptionId=a340138e48a, topicName=PCS)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=173d28230918, createdName=Tamikia, createdTime=Tue Feb 04 13:38:00 CST 2014, time=2014-02-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1478109, encodeId=dfa114e810975, content=<a href='/topic/show?id=f51a8556cc' target=_blank style='color:#2F92EE;'>#HCM#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=8556, encryptionId=f51a8556cc, topicName=HCM)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8e886, createdName=仁者大医, createdTime=Thu Nov 28 02:38:00 CST 2013, time=2013-11-28, status=1, ipAttribution=)]
    2014-02-25 zhaohui6731
  4. [GetPortalCommentsPageByObjectIdResponse(id=1801203, encodeId=b6d118012035c, content=<a href='/topic/show?id=d4bce344265' target=_blank style='color:#2F92EE;'>#研究获进展#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73442, encryptionId=d4bce344265, topicName=研究获进展)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0ad8182, createdName=axin009, createdTime=Sun Mar 30 04:38:00 CST 2014, time=2014-03-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1652656, encodeId=29e41652656db, content=<a href='/topic/show?id=0bb7491186' target=_blank style='color:#2F92EE;'>#CMV#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4911, encryptionId=0bb7491186, topicName=CMV)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3f5424318202, createdName=wolongzxh, createdTime=Sat Dec 07 00:38:00 CST 2013, time=2013-12-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1966881, encodeId=239e19668816c, content=<a href='/topic/show?id=91298559a0' target=_blank style='color:#2F92EE;'>#HCMV#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=8559, encryptionId=91298559a0, topicName=HCMV)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bf3d82, createdName=zhaohui6731, createdTime=Tue Feb 25 04:38:00 CST 2014, time=2014-02-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1685557, encodeId=98de168555e49, content=<a href='/topic/show?id=a340138e48a' target=_blank style='color:#2F92EE;'>#PCS#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13874, encryptionId=a340138e48a, topicName=PCS)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=173d28230918, createdName=Tamikia, createdTime=Tue Feb 04 13:38:00 CST 2014, time=2014-02-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1478109, encodeId=dfa114e810975, content=<a href='/topic/show?id=f51a8556cc' target=_blank style='color:#2F92EE;'>#HCM#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=8556, encryptionId=f51a8556cc, topicName=HCM)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8e886, createdName=仁者大医, createdTime=Thu Nov 28 02:38:00 CST 2013, time=2013-11-28, status=1, ipAttribution=)]
    2014-02-04 Tamikia
  5. [GetPortalCommentsPageByObjectIdResponse(id=1801203, encodeId=b6d118012035c, content=<a href='/topic/show?id=d4bce344265' target=_blank style='color:#2F92EE;'>#研究获进展#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73442, encryptionId=d4bce344265, topicName=研究获进展)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0ad8182, createdName=axin009, createdTime=Sun Mar 30 04:38:00 CST 2014, time=2014-03-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1652656, encodeId=29e41652656db, content=<a href='/topic/show?id=0bb7491186' target=_blank style='color:#2F92EE;'>#CMV#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4911, encryptionId=0bb7491186, topicName=CMV)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3f5424318202, createdName=wolongzxh, createdTime=Sat Dec 07 00:38:00 CST 2013, time=2013-12-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1966881, encodeId=239e19668816c, content=<a href='/topic/show?id=91298559a0' target=_blank style='color:#2F92EE;'>#HCMV#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=8559, encryptionId=91298559a0, topicName=HCMV)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bf3d82, createdName=zhaohui6731, createdTime=Tue Feb 25 04:38:00 CST 2014, time=2014-02-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1685557, encodeId=98de168555e49, content=<a href='/topic/show?id=a340138e48a' target=_blank style='color:#2F92EE;'>#PCS#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13874, encryptionId=a340138e48a, topicName=PCS)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=173d28230918, createdName=Tamikia, createdTime=Tue Feb 04 13:38:00 CST 2014, time=2014-02-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1478109, encodeId=dfa114e810975, content=<a href='/topic/show?id=f51a8556cc' target=_blank style='color:#2F92EE;'>#HCM#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=8556, encryptionId=f51a8556cc, topicName=HCM)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8e886, createdName=仁者大医, createdTime=Thu Nov 28 02:38:00 CST 2013, time=2013-11-28, status=1, ipAttribution=)]
    2013-11-28 仁者大医